Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

So-Called Rare Diseases Are Too Common to Ignore

Posted on June 19th, 2017 by in Pharma R&D

It’s time to re-think our attitude towards rare diseases. Even though relatively few people suffer from any given rare disease, there are so many of these maladies that it’s a surprisingly large swath of the population that is actually victimized by them. Continue reading “So-Called Rare Diseases Are Too Common to Ignore” »

Changing perceptions by measuring inputs and outputs?

Posted on May 12th, 2017 by in Pharma R&D

 

Perception is reality. I am sure everyone will have had an experience (or will do so shortly) where their perception of a situation is at odds with the perception of another. We all have our individual styles and preferences. Continue reading “Changing perceptions by measuring inputs and outputs?” »

Introducing e-Therapeutics: An In Silico Drug Discovery Lab

Posted on May 1st, 2017 by in Chemistry

When laypeople think of drug development, they almost certainly imagine clinical labs filled with chemistry and biology labware or trials with control and test groups receiving different doses of the proposed new treatments. Continue reading “Introducing e-Therapeutics: An In Silico Drug Discovery Lab” »

Clean food, gut bacteria, and drug effects: Is diet another variable drug development?

Posted on March 9th, 2017 by in Pharma R&D

There has been quite a lot of press coverage in the UK recently regarding clean eating, and a variety of recipes and websites offering advice are becoming quite popular. Continue reading “Clean food, gut bacteria, and drug effects: Is diet another variable drug development?” »

  1. 1
  2. 2
  3. 3
  4. 6